Clinical Trials

Clinical trials are the last phase, in a long list of phases, of research done before a new drug or treatment is approved for the market. These trials can vary in size from a single center in one place to multicenter trials in multiple places. Generally, people must meet certain criteria to participate in these trials. These patients benefit from receiving otherwise unavailable treatments. The Immune Tolerance Network has a great checklist to help you decide if clinical trial participation is right for you.

Below, we have listed a number of different sites that can help you find the trials you are interested in and qualify for.

  • The JDRF Type 1 Diabetes Clinical Trials Connection is here to help people with type 1 diabetes better understand what is involved in participating in a clinical trial and to simplify the process of finding trials that may be of interest to them or to their family members.
  • The AMCR Institute conducts leading-edge clinical trials for many leading pharmaceutical and medical device companies. They bring novel and most advanced technologies and treatments to the greater San Diego and Inland Empire areas. Visit their site for more info.
  • Mayo’s clinical trials include experimental treatments, often unavailable elsewhere, which frequently lead to improved patient care for people worldwide.
  • Children With Diabetes list a number of clinical trials looking for participants.
  • NIDDK list Type 1 diabetes trials.
  • Center Watch is a terrific source for information on Diabetes Clinical Trials, as well as new drugs. If you have any complications and are interested in the latest treatments, start here.
  • The National Institutes of Health has a search engine to find the clinical trials that interest you
  • Type 1 Diabetes TrialNet is an international network of researchers who are exploring ways to prevent, delay, and reverse the progression of type 1 diabetes.
  • Viacyte is developing a cell replacement therapy to free people with insulin dependency from injections, strict diet regimens, constant blood sugar monitoring, and serious chronic health conditions associated with diabetes. In August of 2014, their IND (Investigational New Drug) application was accepted by the FDA. They are now initiating Phase 1/2 clinical trials in patients with type 1 diabetes. The trial will evaluate the safety and efficacy of ViaCyte’s VC-01 product candidate, a stem cell-derived, encapsulated cell replacement therapy. See the clinical trial here